Liver Transplant CGM

Recruiting now

Conditions studied: Liver Transplant, Post Transplant Diabetes, Type 2 Diabetes

In brief

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Key facts

Study ID

NCT07216508

Run by

Icahn School of Medicine at Mount Sinai

People needed

40

Starts

2025-10-13

Expected to finish

2027-10-05

Last updated by the study team

2025-11-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL

You may not qualify if…

• having a planned discharge to a rehabilitation or nursing facility,
• a contraindication to sensor placement,
• if discharge is anticipated to be >30 days post-transplant, or
• if recent transplant also included a kidney or pancreas transplant

Where it is running

• Mount Sinai Hospital — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.